TPH2 Recombinant Antibody [PSH04-89] - Guinea pig IgG2 (Chimeric) - BSA and Azide free
cat.: HA610322
Product Type: Recombinant Chimeric Antibody, primary antibodies
Species reactivity: Mouse, Rat
Applications: IHC-Fr, WB
Clone number: PSH04-89
Form: Liquid
Storage condition: Store at +4℃ after thawing. Aliquot store at -20℃. Avoid repeated freeze / thaw cycles.
Storage buffer: 1*PBS (pH7.4).
Concentration: 1ug/ul
Purification: Protein A affinity purified.
Molecular weight: Predicted band size: 56 kDa
Immunogen: Recombinant protein with Human THP2 aa 1-490.
Positive control: Mouse brain tissue lysate, Rat brain tissue lysate.
Subcellular location: Cytosol, neuron projection.
Recommended Dilutions:
  IHC-Fr
  WB

1:200-1:500
1:5,000
Uniprot #: SwissProt: Q8CGV2 Mouse | Q8CGU9 Rat
Alternative names: MGC138871 ADHD7 FLJ37295 MGC138872 Neuronal tryptophan hydroxylase NTPH TPH 2 Tph2 TPH2_HUMAN Tryptophan 5-hydroxylase 2 Tryptophan 5-monooxygenase 2 Tryptophan hydroxylase 2
Images
HA610322_1.jpg Fig1: Application: IHC-Fr

Species: Mouse

Site: Raphe nucleus

Sample: Frozen section

Antibody concentration: 1/500

Antigen retrieval: Not required
HA610322_2.jpg Fig2: Western blot analysis of TPH2 on different lysates with Guinea pig anti-TPH2 antibody (HA610322) at 1/5,000 dilution.

Lane 1: Mouse brain tissue lysate
Lane 2: Mouse kidney tissue lysate (negative)
Lane 3: Rat brain tissue lysate
Lane 4: Rat kidney tissue lysate (negative)

Lysates/proteins at 20 µg/Lane.

Predicted band size: 56 kDa
Observed band size: 50 kDa

Exposure time: 3 minutes; ECL: K1801;

4-20% SDS-PAGE gel.

Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA610322) at 1/5,000 dilution was used in primary antibody dilution (K1803) at 4℃ overnight. Rabbit anti-Guinea pig IgG H&L - HRP Secondary Antibody (HA1021) at 1/50,000 dilution was used for 1 hour at room temperature.
Note: All products are “FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE”.